Last reviewed · How we verify
Sunitinib malate capsules generic product
Sunitinib malate capsules generic product is a Small molecule drug developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | Sunitinib malate capsules generic product |
|---|---|
| Sponsor | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sunitinib malate capsules generic product CI brief — competitive landscape report
- Sunitinib malate capsules generic product updates RSS · CI watch RSS
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. portfolio CI
Frequently asked questions about Sunitinib malate capsules generic product
What is Sunitinib malate capsules generic product?
Sunitinib malate capsules generic product is a Small molecule drug developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd..
Who makes Sunitinib malate capsules generic product?
Sunitinib malate capsules generic product is developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (see full Chia Tai Tianqing Pharmaceutical Group Co., Ltd. pipeline at /company/chia-tai-tianqing-pharmaceutical-group-co-ltd).
What development phase is Sunitinib malate capsules generic product in?
Sunitinib malate capsules generic product is in Phase 1.